ASL Pharma unveiled its new brand identity and headquarters in Kuala Lumpur, marking its evolution into a structured, quality-focused compounding…
Healthcare sector outlook positive; global demand for GLP-1 drugs, medical tourism, glove recovery, and halal pharmaceuticals drive Malaysia’s growth.
China’s biotech and specialty pharma sectors are regaining momentum as policy risks ease and global demand drives earnings recovery.
Malaysia positions itself as ASEAN’s healthcare hub as industry leaders convene at the 2nd Pharma & Healthcare Business Expo 2025.
Trump imposes tariffs on China, Mexico, Canada, aiming to boost U.S. manufacturing, especially in pharma, potentially increasing consumer prices and…
This website uses cookies.